Key result
Age <1 year linked to ~172% higher 30-day readmission risk versus ages 13-19 in surgical oncology.
Why the study?
Factors associated with unplanned readmissions in pediatric surgical oncology patients are largely unknown despite their increased risk.
Cohort (n=2,507)
Yes
Odds Ratio: 2.72 (95% CI 1.72–4.29)
Unplanned 30-day readmissions are prevalent in pediatric surgical oncology patients, with infants and those with advanced or CNS disease at highest risk.
May inform infant-specific discharge planning in pediatric surgical oncology; hypothesis-generating and requires prospective validation.
Purpose Pediatric oncology patients are at increased risk of unplanned readmissions, but factors associated with readmissions are largely unknown. We aimed to identify patients at increased risk for readmission and characterize unplanned readmissions for pediatric surgical oncology patients. Methods Patients < 20 years with a first primary solid organ cancer who underwent definitive oncologic surgery from 2005–2017 were identified in the California Cancer Registry linked to statewide hospitalization data. Unplanned 30-day readmissions from their definitive surgery were defined as acute medical problems and/or surgical complications not related to planned admissions for chemotherapy, radiation, or rehabilitation. Multivariable logistic regression identified factors associated with unplanned 30-day readmission. Results 2507 pediatric oncology patients were identified. Median age was 10 years. 49.2% had a 30-day readmission (n = 1233), and 36.7% (n = 452) of these readmissions were unplanned. In multivariable models, those at highest risk of unplanned readmission were < 1 year old (OR 2.72, CI 1.72–4.29) and 1–5 years (OR 1.64, CI 1.20–2.24) vs. ages 13–19; had metastatic disease at diagnosis (OR 1.6, CI 1.1–2.1); and had central nervous system (CNS) tumors (OR 2.5, CI 1.6–3.9), hepatic tumors (OR 2.3, 95% CI 1.2–4.2), or soft tissue/extraosseous sarcomas (OR 2.2, CI 1.3–3.9). Longer initial hospitalizations were associated with a higher likelihood of unplanned readmission (10 days vs. 7 days, p < 0.0001). Conclusion Unplanned readmissions after surgery for pediatric oncology patients are prevalent. Younger children and those with more advanced/complex disease are at highest risk of unplanned readmissions. Interventions should focus on preventing readmissions in these patients, specifically.
No takes yet. Share an insight, caveat, or question.
Doyle et al. (2024) conducted a cohort in Pediatric solid organ cancer (n=2,507). Age < 1 year vs. Ages 13-19 was evaluated on Unplanned 30-day readmission (OR 2.72, 95% CI 1.72-4.29). Age < 1 year was associated with a significantly higher risk of unplanned 30-day readmission compared to ages 13-19 in pediatric surgical oncology patients (OR 2.72; 95% CI 1.72-4.29).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: